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Objective: Autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder
(ADHD), and anxiety are three of the most common childhood psychiatric disorders.
Early trajectories of social avoidance have been linked with these psychiatric disorders
in previous studies, but it remains unclear how social avoidance differentially predicts
comorbid disorders in a high-risk genetic subgroup. Here, we delineate the association
between trajectories of social avoidance from infancy and subsequent ASD, ADHD,
and anxiety outcomes at preschool in children with fragile X syndrome (FXS), a
well-characterized single-gene disorder highly associated with social avoidance as well
as elevated rates of ASD, ADHD, and anxiety.
Method: Males with FXS (n = 78) aged 4–62 months participated in a longitudinal
study resulting in 201 assessments. The Social Avoidance Scale (SAS) documented
socially avoidant behaviors from infancy in three domains—physical movement, facial
expression, and eye contact during both the first minute and the last hour of an
interaction. ASD, ADHD, and anxiety symptom outcomes at preschool were measured
via parent-report questionnaires.
Results: Increased social avoidance across infancy and preschool predicted elevated
ASD symptom severity but reduced ADHD and anxiety symptom severity in males
with FXS.
Conclusion: ASD, ADHD, and anxiety symptoms relate inconsistently to social
avoidance behaviors, providing new insight toward the debate of independence or
overlap among these disorders in FXS and other disorders (i.e., ASD). The results suggest
that the nuanced profile of the developmental and temporal aspects of social avoidance
may inform more the accuracy of differential diagnoses of comorbid psychiatric disorders
in FXS.
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INTRODUCTION
Psychiatric disorders are debilitating and common, affecting
more than one in five children (1). Autism spectrum disorder
(ASD) is one of the most common and impairing disorders
affecting nearly 2% of the general population (2). The
diagnosis of ASD is complicated, however, given the common
co-occurrence of other disorders. Attention-deficit/hyperactivity
disorder (ADHD) and anxiety are two psychiatric disorders that
often present in children with ASD. Differential diagnosis of
ASD, ADHD, and anxiety in young children is challenging given
the subtlety of behavioral features in early development coupled
with the presence of features that represent typical variation
or overlap across multiple disorders. Adopting a developmental
trajectory approach to capture variation linked to the emergence
of psychiatric disorders will increase understanding of the timing
and targets for both prevention and intervention (3). As such,
studies that identify precursors or symptoms of ASD, ADHD,
and anxiety in infancy and track these symptoms over time until
the age of diagnosis hold great promise to advance psychiatric
research. Of interest to this study, social avoidance is a core
or associated feature of ASD, ADHD, and anxiety that often
presents early in development (4, 5). Identifying developmental
trajectories of social avoidance in groups at high risk for ASD,
ADHD and anxiety is likely to advance our understanding of
both the emergence and independence of features across these
common and impairing psychiatric disorders.
While mean levels of symptom impairment may index risk for
psychiatric disorders, clear evidence suggests that developmental
trajectories representing change or stability can be uniquely
predictive (4, 6). For example, infants later diagnosed with
ASD display reduced avoidance at 6 months-of-age followed by
increased levels of avoidance that emerge at 12 months-of age
and continue through preschool (7, 8). Similarly, trajectories of
change in avoidance and reactivity across the first years, but not
mean levels at any specific age, predict ASD outcomes (9). Also,
a stable trajectory of reduced avoidance from infancy through
preschool characterize children later diagnosed with ADHD (10,
11). Finally, both high and stable levels, as well as steep increases
of social avoidance and stranger fear from 6 to 36 months-of-age,
has been linked to elevated risk for anxiety in preschool (6, 12)
through to middle childhood (4).
Whereas most studies of social avoidance have focused
on “typically developing” children, examining social avoidance
trajectories in genetic subgroups at elevated risk for ASD,
ADHD, and anxiety may inform biological influences on
symptom emergence, as well as the generalizability of social
avoidance research conducted in non-clinical samples to clinical
groups. Fragile X syndrome (FXS) is a well-characterized single-
gene disorder highly associated with co-occurring features
of ASD, ADHD, and anxiety, making the disorder an ideal
candidate for studying social avoidance trajectories in a “high
risk,” genetically-defined sample. FXS is the most common
inherited cause of intellectual disability (ID), affecting ∼1 in
4,000 males and 1 in 8,000 females (13). FXS is caused by
a cytosine-guanine-guanine (CGG) expansion and subsequent
methylation of FMR1 gene on the Xq27.3 site resulting in reduced
FMRP, the protein associated with FXS. Males with FXS are
typically more severely affected given random X inactivation in
females associated with elevated FMRP. Along with moderate
ID, 50–70% of males with FXS meet criteria for ASD (14,
15) and 53–73% meet criteria for ADHD (16, 17). Anxiety
is also highly prevalent, affecting over 85% of males (18).
In addition, social avoidance—a feature also associated with
ASD, ADHD, and anxiety—is a hallmark characteristic of 82–
98% of males with FXS (19–21). The phenotypic overlap of
FXS with ASD, ADHD, and anxiety offers an ideal model for
understanding gene-brain-behavior relationships in a simplified
genetic context (22).
The validity and independence of ASD, ADHD, and anxiety
disorders in FXS has been challenged, not surprisingly, with
debate regarding whether they represent “true” comorbidities
or whether co-occurring symptomology shared across these
disorders results in artifactual diagnostic categorization (21, 23).
For example, poor eye contact is a nearly universal feature of FXS
(24–26); yet, it is not clear whether poor eye contact indexes the
presence of ASD or anxiety, both ASD and anxiety or neither
ASD nor anxiety in FXS. These questions of “true” diagnoses
and the confounding association of anxiety symptomatology
and social avoidance are also debated in the non-syndromic
ASD field (27, 28). Exploring the trajectory of specific traits
that are common across disorders can provide valuable insight
into the distinction and potential overlap among multiple
psychiatric outcomes.
Social avoidance is a core or associated feature of ASD, ADHD,
and anxiety and is a hallmark characteristic of males with FXS
(25, 26). In a recent study (29), we confirmed initial reports that
social avoidance inmales with FXS is elevated throughout infancy
and early childhood relative to age-matched typically-developing
control subjects, with 73% of males with FXS exhibiting social
avoidance. Furthermore, this work suggests that social avoidance
in males with FXS emerges in infancy and increases in severity
across early childhood, becoming more stable in adolescence
and early adulthood. However, little work has focused on the
relationship of social avoidance to the symptoms of ASD,
ADHD, and anxiety across development. In the current study,
we extend previous work (25, 26) to characterize the association
between trajectories of social avoidance and subsequent ASD,
ADHD, and anxiety outcomes in FXS from infancy through
preschool. ASD and ADHD are two of the earliest emerging
childhood disorders, typically presenting before 5 years of age
(30–32). In contrast, anxiety disorders are most commonly
identified during late childhood and adolescence (33). However,
features of anxiety are evident during the infant and preschool
years, and anxiety can be diagnosed in preschool-aged children
(34). Given clear evidence that ASD, ADHD, and anxiety have
optimal outcomes when recognized and treated early (35–37),
our focus on the very early years of life is critical for maximal
translational effects.
Using a prospective longitudinal design, we examined the
relationship between trajectories of social avoidance from infancy
to the severity of ASD, ADHD, and anxiety outcomes at
preschool in males with FXS. We hypothesize that males
with FXS who exhibit higher ASD and anxiety symptoms will
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exhibit higher levels of social avoidance that will intensify
across age. This relationship will not be present in ADHD
outcomes. This hypothesis is based on the fact that social
avoidance is a core feature of both ASD and anxiety, whereas
in ADHD, social avoidance may present as a secondary product
of attention-related difficulties in managing social situations.
Distinguishing the relationship of the level and trajectories of
social avoidance to ASD, ADHD, and anxiety in FXS will provide
novel information about their differential impact on these three
psychiatric disorders that occur frequently and are very impairing
in this population. As such, this work is critical to improve
differential diagnostic processes and direct targeted treatment.
METHODS
Participants
Participants were drawn from two sites that conducted
longitudinal studies and included the measures reported here
(University of South Carolina and University of North Carolina,
Chapel Hill). Participant’s parents at all sites provided written
informed consent prior to participation. All of these studies
focused on documenting the phenotype of FXS across early
development with identical procedures and a subset of common
measures. The age of the samples, however, varied across
studies with some focused on infants while others focused on
preschoolers. Participants were drawn from these studies if they
were male, under 6 years of age and had at least one assessment
that included all of the measures listed below. The advantage
of including data from multiple studies allows us to generalize
across contexts so our findings are not restricted to one discrete
age group and to increase the sample size given the relatively low
prevalence of FXS. All participants with FXS were recruited from
past studies, national parent listservs, social media, the National
Fragile X Foundation, and the Research Participant Registry
Core of the Carolina Institute for Developmental Disabilities
at the University of North Carolina at Chapel Hill. The full
mutation of the FMR1 gene (>200 CGG repeats) was confirmed
through genetic testing. Subsets of these data have been published
previously (25, 26); however, data including this large sample for
the SAS and the inclusion of three psychiatric outcomes have not
been published.
From the potential pool of participants, 74 males with FXS
representing 201 assessments met criteria for study inclusion.
Chronological age at the first assessment ranged from 4 to 62
months (M= 27.31months, SD= 15.12) while chronological age
at the outcome assessment ranged from 23.28 to 70.10months (M
= 51.81, SD= 13.22). The average time between the first and final
assessment was 29.39 months (range of 11.04 to 59.64 and SD =
12.10). Nine participants only had one assessment, whereas the
rest (n= 65) had 2 or more assessments.
Measures
Social Avoidance Scale
The Social Avoidance Scale [SAS; (25, 26)] is an experimental
observation scale used to document socially avoidant behaviors
in three domains: physical movement, facial expression, and
eye contact. Higher ratings represent more socially avoidant
behaviors. Two ratings are assigned for each of the three SAS
subscales, the first rating is based on the first minute of social
interaction and the second rating is based on the last hour
of structured social interaction. Parents were present for both
periods of interaction. This results in six SAS ratings (three first-
minute and three last hour). Intra-class correlation coefficients
(ICCs) reflect a moderate to high degree of reliability between
raters on all of the SAS scales, with a range from 0.82 to 0.90.
The capacity for the SAS to capture dynamic aspects of social
avoidance is central given evidence that a decrease in avoidance
between the two ratings is a core feature of FXS and one that
differentiates those with and without comorbid ASD (25, 26). The
SAS was completed at every assessment point, and the ratings
taken at the first minute and last hour for each of the three
domains were used as the independent variables to predict ASD,
ADHD, and anxiety symptom severity at the final assessment
within each age cohort.
Autism Spectrum Disorder (ASD) Symptom Severity
ASD severity was measured using the Childhood Autism Rating
Scale [CARS; (38)], an observational rating scale comprised of
15 items that measures specific ASD features, such as non-
verbal and verbal communication and adaptation to change, for
individuals from 2 years of age. While the Autism Diagnostic
Observation Scale-2 [ADOS-2; (39)] is recognized as the most
robust diagnostic measure of ASD, we utilized the CARS for this
study as we were focused on ASD symptoms and not diagnoses
and only a subset (∼40%) had an ADOS-2 while all participants
had a CARS. Also, we have documented a strong relationship
between CARS ratings and ADOS-2 continuous severity scores
in males with FXS [r= 0.90; (40)]. In our sample, 48.72% had
CARS raw scores of 30 or above suggesting the presence of ASD.
The total raw score of the CARS at the final assessment was used
as the dependent variable in the ASD models.
Attention Deficit/Hyperactivity Disorder (ADHD)
Symptom Severity
The ADHD Problems scale of the CBCL was utilized to measure
ADHD symptoms. The ADHD subscale assesses symptoms
including inability to sit still, talking too much, and failing to
concentrate for long periods of time. In our sample, 56.41% had
scores above the clinical cutoff suggesting a high likelihood of
ADHD. Due to potential floor and ceiling effects in standardized
scores and the fact that the t-scores are restricted to 50 and
above, the raw score of the CBCL ADHD Problems at the
final assessment was used as the dependent variable in the
ADHDmodels.
Anxiety Symptom Severity
Anxiety symptoms were measured using the DSM Anxiety
Problems scale of the Child Behavior Checklist [CBCL; (40)],
a parent questionnaire assessing emotional and behavioral
problems in children. Parents completed the CBCL version
appropriate for their child’s age (CBCL 1.5–5 Years; CBCL 6–
18 Years). The DSM Anxiety Problems scale assesses symptoms
associated with anxiety, such as worries, fears about going to
school, and clinging to adults. In our sample, 7.70% had scores
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above the clinical cutoff suggesting a high likelihood of having
anxiety. Due to potential floor and ceiling effects in standardized
scores and the fact that the t-scores are restricted to 50 and
above, the raw score of the CBCL Anxiety Problems scale at
the final assessment was used as the dependent variable in the
anxiety models.
Developmental Level
The Mullen Scales of Early Learning (41) is a standardized
developmental measure of abilities for children from birth to
68 months. The Early Learning Composite (ELC), an overall
estimate of cognitive functioning, was used to analyze the effect
of developmental level on measures of social avoidance, ASD,
ADHD, and anxiety.
Procedure
A standard battery of direct child assessments that
included developmental and temperament assessments and
parent/caregiver rating scales was administered by trained
personnel over the course of 2 days [see (42, 43) for more
details]. To control for potential effects associated with variation
in the assessments across sites and given our primary interest
on initial social avoidance, this study focused on SAS ratings for
Day 1 only. Across all sites, the SAS and developmental measures
were completed at each assessment. All available SAS ratings
were included to generate the trajectories of social avoidance,
and the ASD, ADHD, and anxiety outcome data were restricted
to the single assessment at the child’s oldest age. All procedures
were implemented with approval from the institutional review
boards at each respective site.
Data Analytic Plan
Analyses were conducted using SPSS 24 (44), R Core Team
(45), and Mplus Version 8 (46). As preliminary analyses,
we calculated Pearson correlations between ASD, anxiety, and
ADHD symptoms, controlling for developmental level, to
coarsely assess overlap among symptom profiles and inform
structure of subsequent models. Results indicated no relationship
between CARS and both anxiety (r = −0.004; p = 0.972)
and ADHD (r = 0.170; p = 0.162). Anxiety and ADHD were
moderately related (r = 0.240; p= 0.047). Thus, separate models
were used for each outcome. We analyzed our primary research
questions using random effect latent variable models, which
account for variable assessment intervals. Specifically, we used
2-level random slope and intercept model with continuous child-
level outcomes. The two levels of our model correspond to (1)
variation within child (i.e., child observations across time nested
within child) and (2) variation between children. Our model is
represented in Figure 1.
In the within portion of our model (i.e., Level 1), we regressed
social avoidance measures (i.e., SAS) on the age of the child to
estimate a) a latent slope (i.e., S, the solid circle on top of the line
seen in Figure 1 the within portion of the model) corresponding
to the average unit increment in social avoidance per standard
deviation unit increase in age, and b) a latent intercept (i.e., I,
the solid circle within the SAS box in Figure 1) corresponding to
the social avoidance at the average age. We grand mean centered
FIGURE 1 | Model of analytic plan.
and scaled Age to a variance of 1. We used the grand mean to
center because children were measured at different times, and
some children completed more assessments than others; because
of this, interpretation of child centered (i.e., centering on level 2
clusters) age means would be difficult to interpret. In our models,
the intercept is interpreted as the predicted social avoidance for a
child at the average age of our sample, which is 36.12 months.
In the between portion of our model, we regressed the
aforementioned random slope (the unfilled circle S in Figure 1)
and intercept (the unfilled circle I in Figure 1) on the child-level
outcome (square box Y in Figure 1), which includes measures of
ASD, ADHD, or anxiety at the final assessment. In these models,
the regression lines correspond to the average difference in our
outcome measures per unit difference in the slope and intercept.
This portion of themodel answers both of our research questions,
with question 1 (testing the influence of levels) being answered
by regression of child-level outcome on the latent intercept,
and question 2 (testing the influence of linear trajectory) being
answered by the regressing child-level outcomes on the latent
slope of SAS score by Age.
RESULTS
Describing Intercepts and Slopes
Prior to completing the full models, we first estimated global
(i.e., independent of outcome) slopes and intercepts for each SAS
predictor (physical movement, facial expression, and eye contact)
for the first minute and last hour of interaction. These global
scores are found in Table 1. These scores are constructed using
month-unit measures of age (i.e., as opposed to scaled age as in
our full model). The interpretation of the intercept is the average
SAS score at 36.12months, which is the average age of the sample.
The slope is the average linear difference in social avoidance for
every month increase in Age. Base model results are presented in
Table 2 and base model trajectories are presented in Figure 2.
Estimating the Influence of Slopes and
Intercepts on Outcomes
In our full models, age and SAS scores were scaled to a mean of
zero and variance of one. Results from the full models supported
our hypotheses that SAS levels and trajectories would predict
ASD outcomes. However, our hypothesis that SAS levels and
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TABLE 1 | Demographics table.
Mean (SD)
Age at initial assessment 27.31 (15.12)
Mullen early learning scales composite standard score 58.34 (13.93)
Autism symptoms: childhood autism rating scale-II total
raw score
28.64 (6.62)
ADHD† symptoms: child behavior checklist, DSM scale,
T score
63.16 (8.67)
Anxiety symptoms: child behavior checklist, DSM scale,
T score
54.23 (6.23)
Race %
Caucasian 77.00
African American 5.12
Hispanic or Latino 1.30
Asian 0
American Indian/Alaska Native 1.30
Bi-Racial 15.40
†ADHD, attention deficit hyperactivity disorder.
TABLE 2 | Base model results.
Intercept 95% CI Slope 95% CI
Lower Upper Lower Upper
FIRST MINUTE
Physical movement 2.24 2.10 2.40 0.01 0.01 0.02
Facial expression 1.67 1.50 1.84 0.01 0.004 0.02
Eye contact 2.02 1.74 2.30 0.02 0.01 0.04
LAST HOUR
Physical movement 0.90 0.67 1.10 −0.003 −0.013 0.01
Facial expression 0.70 0.55 0.85 0.001 −0.01 0.01
Eye contact 1.33 1.10 1.60 0.01 −0.001 0.02
trajectories would predict anxiety and ADHD outcomes was only
partially supported (see Table 3 for full results).
ASD Outcomes
Physical avoidance in the last hour but not the first minute
significantly predicted ASD outcomes. We found that both a
higher mean level (B = 5.84(1.67), z = 3.51, p < 0.001, CI[2.58,
9.12]), and a trajectory of increasing physical avoidance (B =
7.93(3.66), z = 2.17, p = 0.030, CI[0.76,15.12]) during the last
hour of interaction predicted more severe ASD symptomology
at outcome. We also found that both a higher mean level (B =
3.16(0.31), z= 10.12, p< 0.001, CI[2.55,3.77]) and a trajectory of
increasing facial expressions of social wariness (B = 51.47(0.15),
z = 355.02, p< 0.001 CI[51.19, 51.75]) during the first minute
of interaction predicted more severe ASD symptomology at
outcome. However, only the mean level, not the trajectory,
of facial expression during the last hour of interaction (B =
8.51(2.50), z = 3.41, p = 0.001, CI[3.61,13.40]) predicted ASD
symptomology. Finally, a higher mean level (B = 8.15(2.52),
z = 3.23, p< 0.001, CI[3.20, 13.10]) of avoidant eye contact
during the first minute of interaction predicted more severe
ASD symptomology at outcome, whereas the trajectory did not.
However, both a highermean level (B= 10.05(2.02), z= 4.97, p<
0.001, CI[6.08, 14.02]) and a trajectory of increasing avoidance of
eye contact (B = 8.22(2.21), z = 3.72, p < 0.001, CI[3.90, 12.55])
during the last hour of interaction predicted more severe ASD
symptomology at outcome.
ADHD Outcomes
For ADHD, only the trajectory of increasing physical avoidance
during the first minute of social interaction predicted decreased
ADHD symptomology at outcome (B=−10.79(3.73), z=−2.89,
p= 0.004, CI[−18.10,−3.47]). No other SAS variables predicted
ADHD outcomes.
Anxiety Outcomes
For Anxiety, only the trajectory of increasing physical avoidance
during the first minute of social interaction predicted decreased
anxiety symptomology at outcome (B = −11.33(5.47), z = 2.07,
p = 0.038, CI[−22.1, −0.61]), No other SAS domains predicted
Anxiety Outcomes.
RESULTS SUMMARY
Collectively, elevated physical avoidance, increased facial
expressions of avoidance, and reduced eye contact were all
predictors of ASD, ADHD, or anxiety outcomes. However, the
relationships were dependent on the timing of the interaction
(i.e., first minute or last hour) and parameter (i.e., average level
or trajectory) with increased social avoidance predicting elevated
ASD severity and, surprisingly, it also predicted reduced ADHD
and anxiety severity at outcome. For ASD outcomes, we found
that elevated physical avoidance, increased facial expressions of
avoidance and reduced eye contact all signaled risk for the later
onset of more severe ASD symptoms. Specifically, elevated levels
of physical movement during the final hour and elevated levels
of facial shyness and avoidant eye contact during both the first
minute and final hour were associated with increased severity
of ASD features. A trajectory of increased avoidance in physical
movement and avoidant eye contact during the last hour and
for the first minute for facial shyness also were associated with
increased severity of ASD outcomes. And, while social avoidance
during initial social encounters provided some signal for the
later onset of ASD symptoms, it was elevated social avoidance
during social encounters with familiar people that reflected
the strongest indicator of more severe ASD symptomology. In
contrast, only trajectories of increasing social avoidance during
initial interactions were associated with reduced severity of
ADHD and anxiety outcomes.
DISCUSSION
Psychiatric disorders are common and impairing in children,
and efforts to increase understanding of the prodromal and
predictive features of these disorders represent significant impact
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FIGURE 2 | SAS predictors across age. (A) SAS first minute predictors across age. (B) SAS last hour predictors across age.
given the known benefits of early intervention. Given the high
rates of ASD, ADHD and anxiety in males with FXS, studies
of the developmental trajectories of symptoms associated with
these psychiatric disorders can impact the timing and targets for
intervention. This work has implications not only for individuals
with FXS but also for those who exhibit features of ASD, ADHD
and anxiety of known or unidentified etiology. Because of the
high rates of comorbidity and the monogenic etiology of FXS,
this population provides a saturated model for risk that includes
more “signal” for detecting meaningful associations than can
be observed in studies of the general population (47). The
overall aim of this study was to document the relationship
of social avoidance to ASD, ADHD and anxiety outcomes in
males with FXS across a critical developmental period when
symptoms and diagnoses are known to emerge. To accomplish
this, we employed the SAS, an experimental observation scale
that incorporates multiple dimensions of social avoidance within
a temporal framework.
Based on our results, increased social avoidance across infancy
and preschool predicted elevated severity of ASD symptoms but
reduced ADHD and anxiety symptoms in males with FXS. A
nuanced set of relationships was apparent with ASD predicted by
specific social avoidance features that were entirely unique from
those that predicted ADHD and anxiety outcomes. Surprisingly,
identical predictors (trajectories of physical avoidance during
initial interaction) emerged for both ADHD and anxiety
outcomes. The trajectory of increasing social avoidance appears
to be one of the most salient features as it predicted ASD,
ADHD, and anxiety outcomes whereas an elevated level of social
avoidance only predicted ASD features. However, it was the
trajectory of initial interactions with unfamiliar people at the
beginning of the assessment (first minute) that predicted reduced
ADHD and anxiety whereas the trajectory of interactions with
both unfamiliar people (beginning of the assessment) and people
who had become more familiar by the end of the assessment (last
hour) predicted ASD. These findings highlight the importance of
capturing social avoidance across multiple domains and the value
of including both initial responses to unfamiliar people as well as
responses to people who have become familiar over the course of
the assessment. Overall, these results suggest that elevated social
avoidance emerging during infancy may be a salient marker for
the onset for ASD and of reduced risk for ADHD and anxiety in
males with FXS.
The finding that multiple indicators of social avoidance across
the infant and preschool years’ signal risk for the emergence of
elevated ASD symptoms is of great importance. ASD is one of
themost prevalent and impairing psychiatric disorders associated
with FXS, and FXS is the leading identified genetic cause of
ASD (22). Despite the importance of studying the association
of ASD and FXS, few studies have identified early markers of
ASD in FXS and most of these are cross-sectional. This focus of
research is becoming increasingly studied, however, with recent
reports indicating that social communication deficits (43, 48),
motor atypicalities and delays (42, 49) along with gaze avoidance
(50) and reduced escape during social challenges (51) may be
detectable within the first years of life and serve as a signal for
ASD risk in males with FXS. Here, we add that elevated levels
and trajectories of increasing social avoidance also serve as risk
markers for ASD in the largest longitudinal sample of infants and
preschool-aged males with FXS to date.
Trajectories of social avoidance across infancy and preschool
were also associated with ADHD and anxiety symptom
outcomes, however, in the opposite direction to that expected
with trajectories of elevated physical avoidance during initial
social interactions predicting lower ADHD and anxiety symptom
severity at outcome. These relationships were unexpected as we
anticipated no relationship with ADHD as social impairment is
an associated, but not core, feature of ADHD. The unexpected
direction of the relationship could signal strong emotion
regulation skills in these children. Per this interpretation,
children who have less severe ADHD and anxiety symptom
outcomes may have learned to manage their emotions by
physically retreating from the source of stress, in this case, the
approach of an unfamiliar person. This finding could also suggest
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TABLE 3 | Slopes and intercepts models.
Intercept z CI lower CI upper Slope z CI lower CI upper
CARS
First minute
Physical movement −2.05 −0.23 −19.44 15.34 39.24 1.14 −28.12 106.61
Facial expression 3.16** 10.12** 2.55 3.77 51.47** 355.02** 51.19 51.75
Eye contact 8.15* 3.23* 3.20 13.10 21.39 1.40 −8.46 51.24
Last hour
Physical movement 5.84** 3.51** 2.58 9.12 7.93∧ 2.17∧ 0.76 15.12
Facial expression 8.51* 3.41* 3.61 13.40 15.39 1.10 −11.92 42.70
Eye contact 10.05** 4.97** 6.08 14.02 8.22** 3.73** 3.90 12.55
ADHD
First minute
Physical movement −4.68 −1.64 −10.28 0.92 −10.787∧ −2.89∧ −18.10 −3.47
Facial expression −0.48 −0.45 −2.55 1.60 −0.80 −0.09 −18.86 17.27
Eye contact −0.30 −0.38 −1.83 1.24 −0.58 −0.37 −3.70 2.53
Last hour
Physical movement −0.03 −0.06 −1.08 1.01 1.95 1.55 −1.08 5.00
Facial expression 0.36 0.53 −0.96 1.67 1.45 0.321 −7.42 10.33
Eye contact 0.39 0.54 −1.01 1.79 1.61 0.50 −4.66 7.88
ANXIETY
First minute
Physical movement 0.83∧ 0.47∧ −2.61 4.26 −11.33 −2.07 −22.06 −0.61
Facial expression 0.86 0.73 −1.44 3.17 −0.005 −0.001 −13.66 13.65
Eye contact 0.18 0.29 −1.01 1.36 1.31 0.61 −2.88 5.50
Last hour
Physical movement −0.03 −0.07 −0.77 0.72 0.00 0.00 −2.15 2.15
Facial expression −0.08 −0.14 −1.25 1.08 0.50 0.14 −6.61 7.61
Eye contact 0.16 0.30 −0.90 1.21 0.60 0.18 −5.98 7.18
**p < .0001; *p < .001; ˆp < .05
a developmental effect in that children with less severe ADHD
and anxiety outcomes may respond to social challenge differently
across age with increasing physical avoidance of novel social
partners more likely at preschool age with less physical avoidance
during the infant and toddler years (52).
The results reported here are consistent with a recent study,
which identified unique and distinct early-life predictors of
ASD and ADHD, but are inconsistent with the same study
documenting overlap in predictors of ASD and anxiety (53).
Specifically, this recent study reported that shyness was associated
with both anxiety and ASD. Here, differences in the relationship
of social avoidance to the three psychiatric outcomes likely reflect
the nature of the different disorders and the developmental
period we have focused on. Increased severity of ASD features
was associated with a number of aspects of social avoidance
including all three dimensions (physical movement, facial
expression, and eye contact) as well as during both initial and
sustained social interactions (first minute and last hour). The
pervasiveness of social avoidance associated with ASD likely
reflects an aloof presentation which is often associated with
non-syndromic ASD profiles (54). In contrast, reduced ADHD
and anxiety symptoms align with an acute, and potentially
adaptive, pattern of social avoidance only during initial social
encounters. Children who do not have elevated ADHD or anxiety
symptoms are more likely to have strong emotion regulation
skills and for those skills to develop and increase across the
preschool period (55, 56). Thus, the pattern of walking away
from a potentially stressful social encounter as an adaptive
response aligns with the nature of these disorders in that children
with elevated ADHD might have little social avoidance and
more impulsivity (57). And, those with elevated anxiety might
be more likely to demonstrate initial social avoidance but to
“warm up” over time.
One of the most important findings of this study is that
ASD, ADHD and anxiety symptoms relate inconsistently to social
avoidance behaviors, providing new insight toward the debate of
independence or overlap among these disorders in FXS and other
disorders (i.e., ASD). As noted above, ASD was the only disorder
in which elevated social avoidance predicted increased severity of
symptoms. In fact, increased social avoidance predicted reduced
symptom severity for ADHD and anxiety. Thus, elevated social
avoidance is a trait that uniquely predicts ASD and not ADHD
or anxiety despite social avoidance being a feature of all three
disorders. Our preliminary correlational analyses confirm this
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conclusion as ASD was not related to either ADHD or anxiety.
This finding regarding the apparent independence across these
disorders is particularly striking considering the high prevalence
of 48.72 and 56.41% for ASD and ADHD who are above the
clinical cut-offs, respectively. These rates are generally consistent
with extant literature (15, 17). In contrast, only 7.70% of males
with FXS were above the clinical cutoff for anxiety which may
have constrained our power to detect a relationship between
anxiety and trajectories of social avoidance. The rate of anxiety
in our sample appears low compared to the fact that over 85%
of older males with FXS meet diagnostic criteria for anxiety (18).
However, no studies exist that document the early presentation
of anxiety in FXS so the validity of its prevalence in our sample
is unknown.
This study has a number of important clinical implications.
First, we demonstrated that both the level and trajectory of
social avoidance show meaningful individual differences in the
expression of ASD, ADHD, and anxiety symptom outcomes in
males with FXS. This suggests that the nature and function
of social avoidance is complex, and caution should be taken
to attend to the nuanced profile of social avoidance to ensure
diagnostic accuracy with developmental and temporal aspects
of social avoidance carefully considered. Specifically, both
initial and prolonged social avoidance should be integrated
into differential diagnoses, and this practice rests on clinical
knowledge and observation as some tools (e.g., ADOS-2, CBCL)
may not be sufficiently sensitive to these clinical factors. Second,
our findings confirm that social avoidance manifests very early
in development, and we extend initial work in this area by
demonstrating that early trajectories of social avoidance may
index risk for ASD while signaling resilience or a protective
factor for ADHD and anxiety in young males with FXS.
This information is critical to inform the timing and targets
for treatment.
Despite inclusion of the largest sample of males with FXS to
date in a study focused on social avoidance and integration of
multiple outcomes with repeatedmeasures, there are a number of
limitations. These include failure to include females and reliance
on behavioral ratings without biomarkers. We also targeted the
first years of life as a critical developmental period as our focus
was on early signs and symptoms vs. diagnoses. However, the
focus on this early childhood period likely constrained our ability
to fully detect the relationship of social avoidance to anxiety
given that symptoms of anxiety emerge later in development
than ASD and ADHD symptoms. Also, with regard to our
models, the average amount of assessments available across
children was three (SD = 1.04), with some children having
as many as five assessments, and some children having as few
as one assessment. Because of this range, we modeled our
trajectories using simple linear trends; however, in reality, these
trends are not likely entirely linear. Thus, our understanding
of how developmental changes in social avoidance influences
later outcomes is constrained to linear trends (i.e., the expected
outcome if children’s social avoidance improves or declines, on
average, over time), rather than more nuanced profiles that could
be estimated with additional data. These are important factors
for future work, as is inclusion of a contrast group to see if these
findings generalize to other clinical or non-clinical groups (e.g.,
non-syndromic ASD or low-risk controls).
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